市場調查報告書
商品編碼
1028213

特殊檢驗市場:現狀分析與預測(2021年∼2027年)

Esoteric Testing Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 218 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

所謂特殊檢驗,是對常規臨床實驗室測試中未檢測到的罕見化學物質或分子的檢查。內分泌學、遺傳學、免疫學、微生物學、分子診斷學、腫瘤學、血清學和毒理學是進行特殊檢驗的領域。內部特殊檢驗通常外包給獨立和專業的臨床參考實驗室。在預測期內,市場將受到罕見和複雜疾病頻率增加以及對早期疾病檢測和治療意識提高所推動。

本報告提供全球特殊檢驗市場調查,市場概要,各領域類型、技術、終端用戶、地區的詳細趨勢,前幾名Start-Ups企業,新型冠狀病毒感染疾病(COVID-19)對市場的影響,收益趨勢,市場成長要素及課題,市場機會,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 調查範圍

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 特殊檢驗產業前幾名Start-Ups企業

第6章 新型冠狀病毒感染疾病(COVID-19)的影響

第7章 全球特殊檢驗市場收益

第8章 全球特殊檢驗市場:各類型

  • 傳染病檢查
  • 內分泌檢查
  • 腫瘤學檢驗
  • 遺傳基因檢驗
  • 毒性檢驗
  • 免疫檢驗
  • 神經檢驗

第9章 全球特殊檢驗市場:各技術

  • 化學冷光免疫測量
  • 酵素免疫分析法
  • 質譜分析
  • 即時PCR
  • 流式細胞技術
  • 無線電免疫測量
  • 其他

第10章 全球特殊檢驗市場:各終端用戶

  • 獨立型 索引實驗室
  • 研究實驗室
  • 醫院內實驗室

第11章 全球特殊檢驗市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 其他地區

第12章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第13章 相關法規

第14章 需求與供給側面分析

  • 需求面分析
  • 供給側面分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 合併、收購

第15章 價值鏈分析

第16章 市場機會

第17章 市場趨勢、洞察

第18章 競爭模式

  • 波特的五力分析

第19章 企業概要

  • Myriad Genetics
    • 基本資料
    • 營業內容
    • 主要的產品/服務
    • 成長策略
    • SWOT分析
    • 財務資訊
    • 近幾年趨勢
  • LabCorp
  • Quest Diagnostics
  • Invitae Corporation
  • Mayo Medical Laboratories
  • Spectra Laboratories
  • Opko Health
  • Miraca Holdings
  • Foundation Medicine
  • Sonic Healthcare

第20章 免責聲明

目錄
Product Code: UMHE21340

Esoteric testing is the examination of uncommon chemicals or molecules that are not detected in conventional clinical laboratory tests. Endocrinology, genetics, immunology, microbiology, molecular diagnostics, oncology, serology, and toxicology are some of the areas where esoteric testing is performed. In-house esoteric testing is usually outsourced to independent and specialized clinical reference laboratories.

Over the forecast period, the market will be driven by an increase in the frequency of rare and complex diseases, as well as increased awareness about early disease detection and treatment. According to the European Commission, rare diseases affect nearly 27 to 36 million individuals throughout Europe. The rapidly growing healthcare sector in developing countries, as well as an increase in the number of sophisticated laboratories providing advanced services, will help the industry flourish. The growing number of baby boomers who are susceptible to a variety of chronic illnesses will have a significant impact on industry growth. North America and Asia-Pacific would be the top two markets for Esoteric Testing, owing to the increasing patient population suffering from chronic diseases and rising increased adoption of rapid diagnostics. Based on type the global Esoteric Testing market is bifurcated into infectious diseases testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and others. Currently, the infectious diseases testing segment dominates the market and is expected to maintain its dominance during the forecast period. The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.

Based on technology the market is divided into Power line chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, flow cytometry, radioimmunoassay, and others. The chemiluminescence immunoassay segment dominated the market in 2020 owing to its advantages over other testing methods, such as high-performance levels, low detection limits; etc.

Based on end-user the market is bifurcated into independent & reference laboratories, research laboratories, and hospital-based laboratories. Currently independent & reference laboratories segment dominates the market and is expected to maintain its dominance during the analyzed period owing to the presence of improved diagnostic equipment and devices.

For a better understanding of the market adoption, the report provides detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for esoteric testing owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.

Some of the major players operating in the market include LabCorp, Quest Diagnostics, Invitae Corporation, Mayo Medical Laboratories, Spectra Laboratories, Opko Health, Miraca Holdings, Foundation Medicine, Myriad Genetics, and Sonic Healthcare.

Global Esoteric Testing Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Esoteric Testing Market is expected to witness a boost on account of the increasing prevalence of rare and infectious diseases.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Esoteric Testing Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Esoteric Testing Market
    • 2.1.1 Main Objective of the Global Esoteric Testing Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER ESOTERIC TESTING INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL ESOTERIC TESTING MARKET REVENUE

8 MARKET INSIGHTS BY TYPES

  • 8.1 Infectious Diseases Testing
  • 8.2 Endocrinology Testing
  • 8.3 Oncology Testing
  • 8.4 Genetic Testing
  • 8.5 Toxicology Testing
  • 8.6 Immunology Testing
  • 8.7 Neurology Testing

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1 Chemiluminescence Immunoassay
  • 9.2 Enzyme-Linked Immunosorbent Assay
  • 9.3 Mass Spectrometry
  • 9.4 Real-Time PCR
  • 9.5 Flow Cytometry
  • 9.6 Radioimmunoassay
  • 9.7 Others

10 MARKET INSIGHTS BY END-USER

  • 10.1 Independent & Reference Laboratories
  • 10.2 Research Laboratories
  • 10.3 Hospital based laboratories

11 MARKET INSIGHTS BY REGION

  • 11.1 NORTH AMERICA ESOTERIC TESTING MARKET
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Rest of North America
  • 11.2 EUROPE ESOTERIC TESTING MARKET
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 United Kingdom
    • 11.2.4 Spain
    • 11.2.5 Italy
    • 11.2.6 Rest of Europe
  • 11.3 ASIA PACIFIC ESOTERIC TESTING MARKET
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Australia
    • 11.3.6 Rest of Asia Pacific
  • 11.4 REST OF THE WORLD ESOTERIC TESTING MARKET

12 ESOTERIC TESTING MARKET DYNAMICS

  • 12.1 Market Drivers
  • 12.2 Market Challenges
  • 12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis
    • 14.2.1 Top Product Launches
    • 14.2.2 Top Business Partnerships
    • 14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 ESOTERIC TESTING MARKET OPPORTUNITIES

17 ESOTERIC TESTING MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1 Porter's Five forces analysis
    • 18.1.1 Bargaining power of Supplier
    • 18.1.2 Bargaining power of Buyer
    • 18.1.3 Industry Rivalry
    • 18.1.4 Availability of Substitute
    • 18.1.5 Threat of new Entrants

19 COMPANY PROFILED

  • 19.1 Myriad Genetics
    • 19.1.1 Key Facts
    • 19.1.2 Business Description
    • 19.1.3 Key Product/Services Offerings
    • 19.1.4 Growth Strategy
    • 19.1.5 SWOT Analysis
    • 19.1.6 Key Financials
      • 19.1.6.1 Revenue Split
      • 19.1.6.2 Financial Overview of Medtronics plc
    • 19.1.7 Recent Developments
      • 19.1.7.1 Product Launch
      • 19.1.7.2 Partnerships
      • 19.1.7.3 Business Expansion and Investments
      • 19.1.7.4 Merger and Acquisition
  • 19.2 LabCorp
  • 19.3 Quest Diagnostics
  • 19.4 Invitae Corporation
  • 19.5 Mayo Medical Laboratories
  • 19.6 Spectra Laboratories
  • 19.7 Opko Health
  • 19.8 Miraca Holdings
  • 19.9 Foundation Medicine
  • 19.10 Sonic Healthcare

20 DISCLAIMER